Article Versions Notes

Skrzypczak D, Skrzypczak-Zielińska M, Ratajczak AE, Szymczak-Tomczak A, Eder P, Słomski R, Dobrowolska A, Krela-Kaźmierczak I. Myostatin and Follistatin—New Kids on the Block in the Diagnosis of Sarcopenia in IBD and Possible Therapeutic Implications. Biomedicines. 2021; 9(10):1301. https://doi.org/10.3390/biomedicines9101301

Skrzypczak, Dorota, Marzena Skrzypczak-Zielińska, Alicja Ewa Ratajczak, Aleksandra Szymczak-Tomczak, Piotr Eder, Ryszard Słomski, Agnieszka Dobrowolska, and Iwona Krela-Kaźmierczak. 2021. "Myostatin and Follistatin—New Kids on the Block in the Diagnosis of Sarcopenia in IBD and Possible Therapeutic Implications" Biomedicines 9, no. 10: 1301. https://doi.org/10.3390/biomedicines9101301

Skrzypczak, D., Skrzypczak-Zielińska, M., Ratajczak, A. E., Szymczak-Tomczak, A., Eder, P., Słomski, R., Dobrowolska, A., & Krela-Kaźmierczak, I. (2021). Myostatin and Follistatin—New Kids on the Block in the Diagnosis of Sarcopenia in IBD and Possible Therapeutic Implications. Biomedicines, 9(10), 1301. https://doi.org/10.3390/biomedicines9101301